Terms: = Lung cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
19 results:
1. Evaluation of a New Method for CyberKnife treatment for Central lung and Mediastinal Tumors by Tracheobronchial Tracking.
Suzuki T; Saito M; Takahashi H; Suzuki H; Makino K; Ueda K; Mochizuki K; Mochizuki Z; Nemoto H; Sano N; Onishi H
Technol Cancer Res Treat; 2024; 23():15330338241232557. PubMed ID: 38378006
[TBL] [Abstract] [Full Text] [Related]
2. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
Dodin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
[TBL] [Abstract] [Full Text] [Related]
3. Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in lung cancer: Idylla versus Digital Droplet PCR.
Léonce C; Guerriau C; Chalabreysse L; Duruisseaux M; Couraud S; Brevet M; Bringuier PP; Poncet DA
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958668
[TBL] [Abstract] [Full Text] [Related]
4. Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India.
Kulshrestha R; Saxena H; Kumar R; Spalgais S; Mrigpuri P; Goel N; Menon B; Rani M; Mahor P; Bhutani I
Monaldi Arch Chest Dis; 2023 Feb; 93(4):. PubMed ID: 36723380
[TBL] [Abstract] [Full Text] [Related]
5. Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study.
Srisongkram T; Weerapreeyakul N
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614109
[TBL] [Abstract] [Full Text] [Related]
6. Surgical resection versus radiotherapy for clinical stage IA lung cancer ≤1 cm in size: A population-based study.
Huang W; Deng HY; Wu XN; Xu K; Li P; Lin MY; Yuan C; Zhou Q
Asian J Surg; 2023 Jan; 46(1):385-393. PubMed ID: 35525696
[TBL] [Abstract] [Full Text] [Related]
7. Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line treatment for Relapsed Small Cell lung cancer (SCLC) in China.
Gong J; Wan Q; Shang J; Qian X; Su D; Sun Z; Liu G
Adv Ther; 2021 Oct; 38(10):5116-5126. PubMed ID: 34417989
[TBL] [Abstract] [Full Text] [Related]
8. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
Singh TP; Sharma A; Sharma A; Bakhshi S; Patel C; Pandey AK; Dhamija E; Batra A; Kumar R
Nucl Med Commun; 2021 Jul; 42(7):818-825. PubMed ID: 33741856
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.
Jiang Y; Zhao J; Zhang Y; Li K; Li T; Chen X; Zhao S; Zhao S; Liu K; Dong Z
J Transl Med; 2018 May; 16(1):138. PubMed ID: 29788985
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of changes in Torque teno virus DNA titer after chemotherapy in patients with primary lung cancer.
Sawata T; Bando M; Nakayama M; Mato N; Yamasawa H; Takahashi M; Okamoto H; Sugiyama Y
Respir Investig; 2018 Mar; 56(2):173-178. PubMed ID: 29548656
[TBL] [Abstract] [Full Text] [Related]
11. A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer.
Cao Y; Zhu X; Zhang Y; Yu C; Liu Y; Sun Y; Dai Z; Guo X; Ju X; Zhang H
Med Dosim; 2018 Autumn; 43(3):207-213. PubMed ID: 28993019
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C; Snee M; Ashcroft L; Appel W; Barlesi F; Bhatnagar A; Bezjak A; Cardenal F; Fournel P; Harden S; Le Pechoux C; McMenemin R; Mohammed N; O'Brien M; Pantarotto J; Surmont V; Van Meerbeeck JP; Woll PJ; Lorigan P; Blackhall F;
Lancet Oncol; 2017 Aug; 18(8):1116-1125. PubMed ID: 28642008
[TBL] [Abstract] [Full Text] [Related]
13. Osimertinib for the treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell lung cancer.
Khozin S; Weinstock C; Blumenthal GM; Cheng J; He K; Zhuang L; Zhao H; Charlab R; Fan I; Keegan P; Pazdur R
Clin Cancer Res; 2017 May; 23(9):2131-2135. PubMed ID: 27923840
[TBL] [Abstract] [Full Text] [Related]
14. Serum torque teno virus DNA titer in idiopathic pulmonary fibrosis patients with acute respiratory worsening.
Bando M; Nakayama M; Takahashi M; Hosono T; Mato N; Yamasawa H; Okamoto H; Sugiyama Y
Intern Med; 2015; 54(9):1015-9. PubMed ID: 25948340
[TBL] [Abstract] [Full Text] [Related]
15. extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
Oh JR; Seo JH; Hong CM; Jeong SY; Lee SW; Lee J; Min JJ; Song HC; Bom HS; Kim YC; Ahn BC
Lung Cancer; 2013 Aug; 81(2):218-25. PubMed ID: 23731740
[TBL] [Abstract] [Full Text] [Related]
16. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
Wang J; Pang QS; Wang P; Wang J; Wang W
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
[TBL] [Abstract] [Full Text] [Related]
17. Four-dimensional multislice computed tomography for determination of respiratory lung tumor motion in conformal radiotherapy.
Leter EM; Cademartiri F; Levendag PC; Flohr T; Stam H; Nowak PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):888-92. PubMed ID: 15936574
[TBL] [Abstract] [Full Text] [Related]
18. A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer.
Mackay HJ; O'Brien M; Hill S; Lees SM; Thatcher N; Smith IE; Dunlop DJ
Clin Oncol (R Coll Radiol); 2003 Jun; 15(4):181-5. PubMed ID: 12846495
[TBL] [Abstract] [Full Text] [Related]
19. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer.
Etiz D; Marks LB; Zhou SM; Bentel GC; Clough R; Hernando ML; Lind PA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):835-46. PubMed ID: 12095548
[TBL] [Abstract] [Full Text] [Related]
